Safety study of HRS-5817 injection in healthy adults
Part of Hormones & metabolism clinical trials.
This early-phase trial tests the safety and tolerability of a new injection called HRS-5817 in healthy volunteers. It helps researchers understand how the drug moves through the body and what side effects it might have.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 55 years old.
- You must be in generally good health (no major medical conditions).
- Your weight should have stayed within about 11 pounds (5 kg) over the past 3 months.
- If you can become pregnant or get someone pregnant, you must agree to use effective birth control and not donate eggs or sperm until 6 months after the last dose.
- You must not be allergic to any part of the study drug or have a history of severe allergies.
- You must not have used any other experimental drug or device in the past 3 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection called HS-20136-2. It looks at what happens to the drug in healthy people and in people with obesity. This helps find safe doses and see how the drug works.
This trial tests a new injection called SHR-2906, first in healthy people to check safety, then in people with obesity to see how well it works. It may help with weight management.
This trial tests a new injection, HEC-007, to see if it is safe in healthy adults and in people who are overweight or obese. It may help with weight management and related health issues.
This trial compares two versions of the study drug HRS9531 in people with overweight or obesity to see which one works better in the body. It may help find a more effective treatment for weight management.
This trial tests an investigational injection called HRS-4729 for weight loss in people with obesity. It checks if the drug is safe and effective when used along with diet and exercise.
This study tests whether a new injectable medication called HRS9531 is safe and well-tolerated in teenagers aged 12–17 with obesity. Researchers will monitor how your body handles the medication and whether it affects your weight.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.